Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 134 results for "ajanta pharma"

Ajanta Pharma to pay interim dividend

This page uses frames, but your browser doesn't Capital Market, 13 hours ago
Board of Ajanta Pharma recommends dividend Capital Market, 1 day ago

35 images for ajanta pharma

Money Control, 1 day ago
Financial Express, 1 day ago
Money Control, 2 weeks ago
BioSpace, 1 month ago
India Infoline, 1 month ago
Financial Express, 1 month ago
Money Control, 1 month ago
Drug Store News, 1 month ago
Financial Express, 1 month ago
First, 1 month ago
Money Control

Ajanta Pharma Q2 net up 26% at Rs 130.66 cr

The company had posted a net profit after tax, minority interest and share of profit of associates of Rs 103.44 crore for the same period of the previous fiscal, Ajanta Pharma said in a filing to BSE.
 Money Control1 day ago Ajanta Pharma reports 26% rise in Q2 consolidated net profit  Finalaya.com1 day ago Ajanta Pharma Q2 net up 26 per cent at Rs 130.66 crore  Financial Express1 day ago

Ajanta Pharma declares interim dividend

Ajanta Pharma Ltd has informed BSE that the Board of Directors of the Company at its meeting held on October 26, 2016, approved the payment of interim dividend of Rs 6 (300 percent) per equity share on the face-value of Rs. 2/- per share for the Financial ...
 Money Control1 day ago Ajanta Pharma Ltd Board declares Interim Dividend of Rs. 6 for 2016-17  Equity Bulls19 hours ago Ajanta Pharma Ltd to announce Q2 results on Oct 26, 2016  Equity Bulls1 week ago Ajanta Pharma to hold board meeting  Business Standard1 week ago

Ajanta Pharma net jumps up by 26% in Q2, interim dividend of 300%

Ajanta Pharma has posted strong growth in net profit during the second quarter ended September 2016. Its consolidated net profit increased by 26.3 per cent to Rs. 130.66 crore from Rs. 103.44 crore and its gross sales increased by 14.6 per cent to ...
 PharmaBiz1 day ago Ajanta Pharma Q2 consolidated net profit jumps to Rs. 130.66 crores  Equity Bulls19 hours ago

Results of Canara Bank, ITC, HUL, Hero MotoCorp, HDFC

Ajanta Pharma, Cadila Healthcare, Canara Bank, Cummins India, Dabur India, Dalmia Bharat, Deepak Nitrite, Arvind Infrastructure, Excel Crop, Exide, Indoco Remedies, HDFC, Hindustan Unilever, Hero Mo...
 Business Line2 days ago Results to watch out for! ITC, HDFC, Hero MotoCorp, HUL in focus  India Infoline1 day ago

Ajanta Pharma Q2 PAT up 27% at Rs 131 crore

Total Income has increased from Rs 447.8 crore for the quarter ended September 30, 2015 to Rs 522.5 crore for the quarter ended September 30, 2016.
 India Infoline1 day ago Equity MFs see inflow of Rs 2,506 crore in July; private banks, NBFCs find favour among funds  Economic Times2 months ago
India Infoline

Top 15 stocks in focus today: Maruti Suzuki, Sun Pharma, Hero MotoCorp

Check out the companies which will be in focus during trade today based on recent and latest news developments. Tech Mahindra: The IT company will announce its Q2 numbers today. Suzlon: Suzlon group has entered into a joint venture with Ostro ...
 India Infoline22 hours ago Top 13 stocks in focus today: Dr. Reddy's Lab, MOIL, A2Z Infra  India Infoline2 weeks ago Top 18 stocks in focus today: ITC, IRB Infra, Gruh Finance  India Infoline2 weeks ago Top 16 stocks in focus today: Reliance Communications, Tata Power, Ashok Leyland  India Infoline1 month ago


A Pharmabiz study of R&D spending by 25 research based Indian pharmaceutical companies reveals that their research expenditure during 2015-16 went up by 24 per cent as compared to the previous year. These 25 companies spent a total amount of Rs ...
 PharmaBiz1 week ago R&D spend by 25 Indian pharma cos jumps by 24% in 2015-16, Sun remains top  PharmaBiz2 weeks ago

2,630 proposals of Intention to invest received

proposals of Intention to Invest were received in two-day Global Investors' Summit held in Indore. They carry proposals of investment to the tune of Rs 5,62,847 crore. Some major proposals are Rs 20,000 capital investment in different sectors by ...
 New Delhi Pioneer3 days ago MP gets investment proposals over Rs.5,62,847 crores in 5th Global Investors Summit  Siasat Daily3 days ago MP receives over Rs 5.5-lakh crore investment proposals  News Track India4 days ago MP Receives Over 5.5-Lakh Crore Investment Proposals  Silicon India3 days ago

Ajanta Pharma gets USFDA nod for Aripiprazole Tablets

Ajanta has 26 Abbreviated New Drug Applications (ANDAs) of which it has 14 final approvals, including the current approval, 2 tentative approvals and 10 ANDAs under review with the US FDA.
 India Infoline1 month ago Ajanta Pharma gets US FDA approval for aripiprazole tablets  PharmaBiz1 month ago Ajanta Pharma announces approval of Aripiprazole tablets from USFDA  Money Control1 month ago Ajanta Pharma receives final approval for Aripiprazole Tablets  Capital Market1 month ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - ajanta pharma
Get updated on latest news & your favorite topics right in your inbox!
More     Less